Gut microbiota metabolic enzyme and transporter

Gut microbiota metabolic enzymes and transporters constitute a vast network of bacterial proteins in the intestines that collectively execute the breakdown, synthesis, and interconversion of nutritional and xenobiotic compounds[2][5]. Enzyme activities include saccharide hydrolysis, protein and peptide breakdown, bile acid conversion, and drug metabolism through diverse mechanisms such as oxidation, reduction, or hydrolysis[3][5]. Key transporter families include major facilitator superfamily, ATP-binding cassette, phosphotransferase systems, and SusCD transporters, facilitating uptake of carbohydrates, amino acids, and other nutrients[1]. These proteins profoundly impact host physiology by generating bioactive metabolites (like short-chain fatty acids and secondary bile acids), modulating immune responses, and shaping the pharmacokinetics of orally administered drugs[2][4]. Therapeutically, dysregulation or manipulation of these enzymes and transporters is implicated in a wide range of diseases including metabolic syndrome, cancer, and inflammatory disorders, making them an emerging target for pharmacotherapy and microbiome-modulating interventions[4]. This entry is considered incorrect as a molecular target because it refers to a large functional category (multiple unrelated enzymes and transporters) rather than a single molecular entity or specific protein typically recognized as a drug target. Future structured data should specify individual enzymes (e.g., microbial β-glucuronidase) or transporters (e.g., microbial acetate transporter) for proper target annotation, classification, and associated drug interactions.

Other names

Microbial metabolic enzymeGut microbial transporterIntestinal microbial enzymeIntestinal microbial transporter

Enzymatic transformation/biotransformation (drug activation/inactivation by hydrolysis, reduction, etc.); Alteration of absorption/metabolism via transporter modulation (carbohydrate, bile acid, and drug import/export); Competitive modulation of host metabolic pathways (e.g., competing with host drug-metabolizing enzymes)